Galderma Announces Regulatory Approval for Restylane® SHAYPE™, a New Hyaluronic Acid Injectable Designed for Augmenting the Chin Region

Contributed by: Business Wire

Logo

Tags

Cosmetics

Lifestyle

Retail

Health

Consumer

Pharmaceutical

Biotechnology

Galderma

More Like This

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio

Galderma Launches Restylane® VOLYME™ in China – One of the World’s Fastest Growing Aesthetics Markets

Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends

IBSA Derma presents the new frontier of adipose tissue restoration in response to aging (Photo: Business Wire)

From the surface to the deep structure of the face: IBSA Derma presents the new frontier of adipose tissue restoration in response to aging

Copyrights - Sylvain Granjon

Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event

Galderma Celebrates 25 Years of Excellence in Biostimulation With Sculptra® at the 2024 IMCAS